News

Pharmabiz43m
Daiichi Sankyo & Merck voluntarily withdraws patritumab deruxtecan BLA to treat locally advanced or metastatic EGFR-mutated NSCLC from US FDA
Daiichi Sankyo & Merck voluntarily withdraws patritumab deruxtecan BLA to treat locally advanced or metastatic EGFR-mutated NSCLC from US FDA: Basking Ridge, New Jersey Friday, Ma ...
Pharmabiz1h
Telangana IDMA elects KV Rambabu of Pulse Pharma as president, Sekhar Rao of TherDose Pharma new secretary
Telangana IDMA elects KV Rambabu of Pulse Pharma as president, Sekhar Rao of TherDose Pharma new secretary: Our Bureau, ...
Pharmabiz1h
KWIN City to get a booster shot as University of Liverpool explores research partnership in lifesciences
Nandita Vijayasimha, Bengaluru Friday, May 30, 2025, 08:00 Hrs [IST] ...
Pharmabiz1h
India reschedules oral hearing in anti-dumping probe on MEG imports from Kuwait, Saudi Arabia & Singapore
Shardul Nautiyal, Mumbai Friday, May 30, 2025, 08:00 Hrs [IST] ...
Pharmabiz1h
Delhi High Court upholds Patent Office's decision on Zeria Pharma's patent application
Delhi High Court upholds Patent Office's decision on Zeria Pharma's patent application: Our Bureau, New Delhi Friday, May 30, 2025, 08:00 Hrs [IST] The Delhi High Court has upheld ...
Pharmabiz15h
Immutep’s efti with radiotherapy and pembrolizumab meets primary endpoint in phase II trials for soft tissue sarcoma
Immutep’s efti with radiotherapy and pembrolizumab meets primary endpoint in phase II trials for soft tissue sarcoma ...
Pharmabiz16h
Govt of Tamil Nadu in association with C-CAMP hosts Roundtable on Health
Govt of Tamil Nadu in association with C-CAMP hosts Roundtable on Health: Our Bureau, Bengaluru Thursday, May 29, 2025, 17:30 ...
Pharmabiz16h
Lilly, Apollo Clinic & Apollo HealthCo partner to drive nationwide awareness on obesity and type 2 diabetes
Lilly, Apollo Clinic & Apollo HealthCo partner to drive nationwide awareness on obesity and type 2 diabetes: Our Bureau, Bengaluru Thursday, May 29, 2025, 17:15 Hrs [IST] Eli Lill ...
Pharmabiz16h
BioIVT & Handok Biotech ink commercial agreement to advance innovation in South Korea
BioIVT & Handok Biotech ink commercial agreement to advance innovation in South Korea: Westbury, New York Thursday, May 29, 2025, 17:00 Hrs [IST] BioIVT, a global research partner ...
Pharmabiz17h
AiMeDs expresses hope that policy and judicial support help domestic firms have level playing field for tenders
Our Bureau, New Delhi Thursday, May 29, 2025, 16:15 Hrs [IST] ...
Pharmabiz17h
US FDA approves Abbott’s Tendyne, first-of-its-kind device to replace the mitral valve without open-heart surgery
US FDA approves Abbott’s Tendyne, first-of-its-kind device to replace the mitral valve without open-heart surgery: Abbott Park, Illinois Thursday, May 29, 2025, 16:00 Hrs [IST] ...
Pharmabiz18h
Bristol Myers Squibb receives European approval for subcutaneous formulation of Opdivo across multiple solid tumour indications
Bristol Myers Squibb receives European approval for subcutaneous formulation of Opdivo across multiple solid tumour indications: Princeton, New Jersey Thursday, May 29, 2025, 15:0 ...